Jerash Holdings JRSH Q1 2026 Earnings EPS Surges Past Estimates with 488 Surprise CIEN Q1 2026 Earnings EPS Surprises to the Upside as Stock Rises Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 VEON Q1 2026 Earnings EPS Surpasses Estimates as Digital Transformation Gains Traction NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances HubSpot HUBS Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 18